Business
Strategic Partnership | Sanyou Bio and Korea's FatiAbGen Join Forces to Expand the Global Biopharma Market
Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. ("Sanyou Bio") and South Korea's FatiAbGen Co., Ltd. today jointly announced the signing of a comprehensive strategic collaboration agreement covering joint project development, exclusive representation in the Korean market, and global market expansion.
About this update from Sanyou Corp. Ltd. Class A
[{"type":"text","content":"SHANGHAI, Nov. 27, 2025 /PRNewswire/ -- Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. ("Sanyou Bio") and South Korea's FatiAbGen Co., Ltd. today jointly announced the signing of a comprehensive strategic collaboration agreement covering joint project development, exclusive representation in the Korean market, and global market expansion.","length":354,"tagName":"p"},{"type":"text","content":"This partnership leverages Sanyou Bio's globally leading AI-STAL drug discovery platform and FatiAbGen's deep local presence in South Korea to drive synergistic growth across Korea, Europe, and beyond — empowering biotech innovators worldwide.","length":261,"tagName":"p"},{"type":"text","content":"The strategic alliance defines a three-pronged cooperation framework:","length":74,"tagName":"p"},{"type":"text","content":"1. The two companies will initiate in-depth R&D collaboration around a specific drug discovery project;","length":107,"tagName":"p"},{"type":"text","content":"2. FatiAbGen will serve as Sanyou Bio's official partner in South Korea, fully representing Sanyou's integrated drug discovery services and products powered by the "AI-STAL Super Trillion Antibody Library";","length":229,"tagName":"p"},{"type":"text","content":"3. Both parties will jointly integrate global resources to expand into the international biopharma market — including Europe — providing world-class R&D solutions to overseas innovative drug developers. To ensure a smooth rollout of the partnership, the FatiAbGen team was invited to visit Sanyou Bio's R&D facilities following the signing ceremony. They also participated in a customized technical training program, equipping them with comprehensive knowledge of Sanyou's service portfolio and cutting-edge technologies — enabling FatiAbGen to deliver professional and precise technical support to Korean clients.","length":640,"tagName":"p"},{"type":"text","content":"JayJay Lee, CEO of FatiAbGen, commented: "We are honored to form a strategic partnership with Sanyou Bio, a global pioneer in new drug discovery. Sanyou's world-class technology platform and integrated solutions perfectly address the early-stage R&D gaps faced by many Korean biotech companies. Through this collaboration, we aim to introduce top-tier ...